A fish cytokine related to human IL-3, IL-5, and GM-CSF, induces development of eosinophil/basophil/mast-cell type (EBM) granulocytes.
Interleukin-3 (IL-3), IL-5, and granulocyte-macrophage colony-stimulating issue (GM-CSF) are related cytokines that sign by way of receptors possessing the β frequent (βc) chain. As a household, these cytokines mix quite non-specific hematopoietic progress issue properties with a particular significance for eosinophils, basophils, and mast cells. In fish the cytokines of this household are known as IL-5fam, and the current examine, utilizing carp, constitutes their first useful evaluation.
Carp il-5fam expression was enhanced by stimulation with phytohemagglutinin and killed micro organism. Reminiscent of mammalian IL-3/IL-5/GM-CSF relations, recombinant carp IL-5fam (rcIL-5fam) induced activation of transcription issue STAT5 and effectively promoted proliferation and colony-formation of eosinophil/basophil/mast-cell type (EBM) granulocytes.
Upon addition of recombinant carp βc the expansion impact of rcIL-5fam was diminished, suggesting βc participation within the signaling route. In abstract, regardless of variations in particular person cytokines and cell populations, fish and mammalian IL-3/IL-5/GM-CSF relations share progress issue features for non-neutrophil granulocytes.
Clinical Physicians’ Attitudes in direction of Evidence-Based Medicine (EBM) and Their Evidence-Based Practice (EBP) in Wuhan, China.
Objective: Numerous research have proved the significance of Evidence-Based Medicine (EBM) in each day scientific observe, nevertheless, clinicians’ attitudes play an vital position in figuring out its implementation. The goal of this examine was to examine Chinese scientific physicians’ notion of and angle in direction of EBM and their Evidence-Based Practice (EBP) in addition to the obstacles in direction of EBP. Methods: Using a cross-sectional design, self-response questionnaires have been distributed to scientific physicians (inside medication and surgical procedure departments) throughout three tertiary hospitals in Wuhan, China. Results: In complete, 131 out of 195 (67.2%) physicians accomplished and returned the questionnaire.
A complete of 64.9% of the physicians both knew reasonably or rather a lot about EBM. The imply rating of physicians’ angle towards EBM was 2.35 ± 0.35, and that of their EBP talent/ competency was 1.51 ± 0.56 (on 0-3 Likert scale). In complete, 76.0% of physicians typically or generally utilized EBM in routine each day observe. The largest barrier stopping implementation was the various particular person variations in ailments (61.0%), adopted by a scarcity of funding from the hospital/division (39.8%), and a scarcity of affected person cooperation (37.4%). Chinese physicians in tertiary hospitals possessed expressed optimistic attitudes in direction of EBM; nevertheless, they solely retained a average stage of scientific proof competency.
Both a person issue (private curiosity) and organizational elements (workload, hospital requirement) had an impact on physicians’ attitudes and their EBP expertise. Management and organizational efforts, as well as to time devoted for EBP initiatives may assist scale back obstacles that stop EBP.
SARC-F Validation and SARC-F+EBM Derivation in Musculoskeletal Disease: The SPSS-OK Study.
To validate the SARC-F questionnaire for sarcopenia screening in musculoskeletal illness setting, and to assess enhancements in diagnostic accuracy by including “EBM” (aged and physique mass index info) to the SARC-F.Diagnostic accuracy examine.The heart concerned on this examine was situated in an city space of Kobe City, Japan. People with musculoskeletal illness within the knee, hip, or backbone who have been scheduled for surgical remedy have been included.Sarcopenia was evaluated utilizing the Asian Working Group for Sarcopenia (AWGS) and the European Working Group on Sarcopenia in Older People (EWGSOP2), which included bioimpedance, handgrip energy, and gait pace. Patients answered the SARC-F questionnaire and their physique mass index was measured. SARC-F and “EBM” info have been mixed into an authentic rating.
The sensitivities, specificities, and areas below the receiver working attribute curve (AUC) have been estimated and in contrast to determine sarcopenia.A complete of 959 sufferers have been included. Sarcopenia by AWGS standards was recognized in 36 (3.8%) sufferers. SARC-F had a sensitivity of 41.7% and specificity of 68.5%. SARC-F+EBM had a sensitivity of 77.8% and specificity of 69.6%, with substantial enchancment in sensitivity (P<0.001). The AUCs for SARC-F and SARC-F+EBM have been 0.557 (95% confidence interval [CI] 0.452-0.662) and 0.824 (95% CI 0.762-0.886), respectively (P<0.001).
Similar outcomes have been obtained when EWGSOP2 standards have been used because the reference normal.The SARC-F alone just isn’t ample for locating circumstances in musculoskeletal illness settings. SARC-F+EBM considerably improved the sensitivity and general diagnostic accuracy of the SARC-F for screening sarcopenia. SARC-F+EBM is probably helpful for screening sarcopenia in numerous ethnic and illness settings.
A comparative examine on the nanoindentation habits, put on resistance and in vitro biocompatibility of SLM manufactured CP-Ti and EBM manufactured Ti64 gyroid scaffolds.
The current examine investigates the nanoindentation habits, put on resistance and in vitro biocompatibility of SLM manufactured CP-Ti and EBM manufactured Ti64 gyroid scaffolds and the outcomes have been in contrast to these of casting CP-Ti. Both the SLM- and EBM manufactured scaffolds exhibited anisotropic properties with greater diminished modulus (up to 10%) and nanohardness (up to 30%) within the transverse course than these in constructing course. The put on resistance of scaffolds in transverse course was greater than these of in constructing course by up to ∼25% and ∼82% for SLM manufactured CP-Ti and EBM manufactured Ti64 scaffolds, respectively.
The SLM manufactured CP-Ti scaffolds displayed important enhancement in put on resistance over solid dense CP-Ti with 75% decrease imply worn peak throughout a nanowear take a look at. The coefficient of friction was various between 0.11 and 0.24 and exhibited a gentle imply worth of 0.15-0.18 for CP-Ti and Ti64 scaffolds, respectively. During in vitro cell tradition examine, CP-Ti scaffolds confirmed greater cell viability and cell adhesion density compared to Ti64 scaffolds for all unit cell sizes.
Moreover, cell adhesion density of scaffolds with smaller unit cell sizes (G2) are decrease than these of bigger unit cells (G3). SEM observations confirmed that each the internal area and surfaces of gyroid scaffolds offered an appropriate setting for cell migration, attachment and proliferation after cell tradition for 7 d. STATEMENT OF SIGNIFICANCE: It is crucial to consider the properties of EBM/SLM manufactured scaffolds and to decide whether or not they can meet the robust efficiency necessities of the biomedical trade.
CXCL8 CRISPR Knock Out L3.6pl Cell Line |
|||
T6220 | ABM | 1x10^6 cells / 1.0 ml | Ask for price |
CXCL1 CRISPR Knock Out L3.6pl Cell Line |
|||
T6221 | ABM | 1x10^6 cells / 1.0 ml | Ask for price |
SIRT CRISPR Knock Out Human HepG2 Cell Line - Clone T3-6 |
|||
T6804 | ABM | 1x10^6 cells / 1.0 ml | Ask for price |
PRSS21 CRISPR Knock Out Human OVCAR8 Cell Line - Clone T2 C8 |
|||
T6811 | ABM | 1x10^6 cells / 1.0 ml | Ask for price |
mAdrb2 CRISPR Knock Out B16 Cell Line (T1-10) |
|||
T9775 | ABM | 1x10^6 cells / 1.0 ml | Ask for price |
TREM2 CRISPR Knock Out Human THP-1 Cell Line - Clone T1-9 |
|||
T6810 | ABM | 1x10^6 cells / 1.0 ml | Ask for price |
PTPN6 CRISPR Knock Out Human THP-1 Cell Line - Clone T3-1 |
|||
T6813 | ABM | 1x10^6 cells / 1.0 ml | Ask for price |
MSLN CRISPR Knock Out Human OVCAR3-A1 Cell Line - Clone T2 C4 |
|||
T6820 | ABM | 1x10^6 cells / 1.0 ml | Ask for price |
NUAK2 CRISPR Knock Out 293T Cell Line - Clone T3 #41 |
|||
T6801 | ABM | 1x10^6 cells / 1.0 ml | Ask for price |
NR2F6 CRISPR Knock Out Human Jurkat E6.1 Cell Line - Clone T3-10 |
|||
T6822 | ABM | 1x10^6 cells / 1.0 ml | Ask for price |
Aldh2 CRISPR Knock Out L929 Cell Line - Clone T3-20 |
|||
T9692 | ABM | 1x10^6 cells / 1.0 ml | Ask for price |
hPIM1 CRISPR Knock Out SACC-83 Cell Line-T3-9 |
|||
T9787 | ABM | 1x10^6 cells / 1.0 ml | Ask for price |
Dcx CRISPR Knock Out C6 Cell Line (Rat) - Clone sg4-1 |
|||
T9624 | ABM | 1x10^6 cells / 1.0 ml | EUR 3950 |
GLT1 CRISPR Knock Out Rat AST Cell Line - Clone T2-1 |
|||
T9678 | ABM | 1x10^6 cells / 1.0 ml | Ask for price |
PTPN11 CRISPR Knock Out NIH/3T3 Cell Line - Clone T4-9 |
|||
T6803 | ABM | 1x10^6 cells / 1.0 ml | Ask for price |
METTL3 CRISPR Knock Out Caki-1 Cell Line - Clone T2-16 |
|||
T9623 | ABM | 1x10^6 cells / 1.0 ml | EUR 3950 |
Nacc1 CRISPR Knock Out ID8 Cell Line (Mouse) - Clone T1-23 |
|||
T9627 | ABM | 1x10^6 cells / 1.0 ml | Ask for price |
osbpl2 CRISPR Knock Out NIH/3T3 Cell Line - T1 Polyclonal Pool |
|||
T9682 | ABM | 1x10^6 cells / 1.0 ml | Ask for price |
CARMIL1 CRISPR Knock Out Immortalized Human Gingival Fibroblast - hTERT Cell Line - T1-2 |
|||
T6825 | ABM | 1x10^6 cells / 1.0 ml | Ask for price |
Aifm1 CRISPR Knock Out Mouse L929 Cell Line - Clone T2-15-3 |
|||
T9674 | ABM | 1x10^6 cells / 1.0 ml | Ask for price |
SEC61G CRISPR Knock Out HCC-LM3 Cell Line - Clone T2-17-5 |
|||
T9746 | ABM | 1x10^6 cells / 1.0 ml | Ask for price |
Cell line gene knock-in and knock-out |
|||
S301 | 101Bio | - | EUR 15000 |
Araf CRISPR Knocked out RAW264.7 Stable cell Cell Line (Mouse) T3-3 |
|||
T9529 | ABM | 1x10^6 cells/1.0ml | EUR 3950 |
Araf CRISPR Knocked out RAW264.7 Stable cell Cell Line (Mouse) T1-19 |
|||
T9511 | ABM | 1x10^6 cells / 1.0 ml | EUR 3950 |
Stable Mouse Myeloid-derived Suppressor-like LAL Knock Out (HD1B) Cell Line |
|||
T3187 | ABM | 1x10^6 cells / 1.0 ml | EUR 3950 |
Human MB knockout cell line |
|||
ABC-KH9065 | AcceGen | 1 vial | Ask for price |
Description: Human MB knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human MB knockdown cell line |
|||
ABC-KD9065 | AcceGen | 1 vial | Ask for price |
Description: Human MB knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
BRCA1 CRISPR Stable Knockout Human Fibroblast Cell Line |
|||
T6245 | ABM | 1x10^6 cells / 1.0 ml | EUR 3950 |
293AD Cell Line |
|||
AD-100 | Cell Biolabs | 1 vial | EUR 365 |
293AAV Cell Line |
|||
AAV-100 | Cell Biolabs | 1 vial | EUR 405 |
293LTV Cell Line |
|||
LTV-100 | Cell Biolabs | 1 vial | EUR 405 |
293RTV Cell Line |
|||
RV-100 | Cell Biolabs | 1 vial | EUR 405 |
PTPRA CRISPR Knockout Immortalized Human Lung Fibroblast Cell Line |
|||
T6827 | ABM | 1x10^6 cells / 1.0 ml | Ask for price |
293/GFP Cell Line |
|||
AKR-200 | Cell Biolabs | 1 vial | EUR 460 |
T47D/GFP Cell Line |
|||
AKR-208 | Cell Biolabs | 1 vial | EUR 686.4 |
Description: T47D/GFP Cell Line stably expresses GFP and otherwise exhibits the same characteristics of the parental cell line. |
A549/GFP Cell Line |
|||
AKR-209 | Cell Biolabs | 1 vial | EUR 460 |
HeLa/GFP Cell Line |
|||
AKR-213 | Cell Biolabs | 1 vial | EUR 460 |
293/Cas9 Cell Line |
|||
AKR-5110 | Cell Biolabs | 1 vial | EUR 460 |
HeLa/Cas9 Cell Line |
|||
AKR-5111 | Cell Biolabs | 1 vial | EUR 460 |
NIH3T3/GFP Cell Line |
|||
AKR-214 | Cell Biolabs | 1 vial | EUR 460 |
NIH3T3/Cas9 Cell Line |
|||
AKR-5104 | Cell Biolabs | 1 vial | EUR 460 |
Human CRISP1 knockout cell line |
|||
ABC-KH3569 | AcceGen | 1 vial | Ask for price |
Description: Human CRISP1 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human CRISP2 knockout cell line |
|||
ABC-KH3570 | AcceGen | 1 vial | Ask for price |
Description: Human CRISP2 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human CRISP3 knockout cell line |
|||
ABC-KH3571 | AcceGen | 1 vial | Ask for price |
Description: Human CRISP3 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
MCF-7/Luc Cell Line |
|||
AKR-234 | Cell Biolabs | 1 vial | EUR 686.4 |
Description: MCF-7/Luc Cell Line stably expresses luciferase and otherwise exhibits the same characteristics of the parental cell line. |
SKOV-3/Luc Cell Line |
|||
AKR-232 | Cell Biolabs | 1 vial | EUR 686.4 |
Description: SKOV-3/Luc Cell Line stably expresses luciferase and otherwise exhibits the same characteristics of the parental cell line. |
OVCAR-5/RFP Cell Line |
|||
AKR-254 | Cell Biolabs | 1 vial | EUR 686.4 |
Description: OVCAR-5/RFP Cell Line stably expresses RFP and otherwise exhibits the same characteristics of the parental cell line. |
PTPN6 Stable Knocked Out THP-1 Cell Line |
|||
T6216 | ABM | 1x10^6 cells / 1.0 ml | EUR 3950 |
Acan CRISPR Knockout RCS Cell Line (Rat) |
|||
T3000 | ABM | 1x10^6 cells / 1.0 ml | Ask for price |
Human MDA-MB-435 |
|||
cAP-0049 | Angio Proteomie | 1Frozen Vial | EUR 396 |
Human CRISPLD1 knockout cell line |
|||
ABC-KH3572 | AcceGen | 1 vial | Ask for price |
Description: Human CRISPLD1 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human CRISPLD2 knockout cell line |
|||
ABC-KH3573 | AcceGen | 1 vial | Ask for price |
Description: Human CRISPLD2 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human CRISP1 knockdown cell line |
|||
ABC-KD3569 | AcceGen | 1 vial | Ask for price |
Description: Human CRISP1 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
Human CRISP2 knockdown cell line |
|||
ABC-KD3570 | AcceGen | 1 vial | Ask for price |
Description: Human CRISP2 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
Human CRISP3 knockdown cell line |
|||
ABC-KD3571 | AcceGen | 1 vial | Ask for price |
Description: Human CRISP3 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
GFP-Human MDA-MB-435(MDA-MB-435) |
|||
ABC-RC211D | AcceGen | 1 vial | Ask for price |
Description: Human MDA-MB-435 is a cell line isolated from the pleural effusion of a 31 year old female with metastatic, ductal adenocarcinoma of the breast. GFP-expressing MDA-MB-435 (GFP-MDA-MB-435) are selected from MDA-MB-435 cells after infected with lentiviruses expressing GFP with puromycin. The cells are shipped in a frozen vial with more than 5 x 105 cells/vial. Universal Full Growth Medium is recommended for cell culture and these cells have an average minimum population doubling levels > 20 when cultured following the detailed protocol described below. |
TARGATT? Knock-in Mouse Cell Line Generation Kit (Master Cell Line) |
|||
AST-7001 | Applied StemCell | 1 Kit | Ask for price |
Description: 6 month |
Human CRISPLD1 knockdown cell line |
|||
ABC-KD3572 | AcceGen | 1 vial | Ask for price |
Description: Human CRISPLD1 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
Human CRISPLD2 knockdown cell line |
|||
ABC-KD3573 | AcceGen | 1 vial | Ask for price |
Description: Human CRISPLD2 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
GFAT1 CRISPR Stable Knockout H1299 Cell Line |
|||
T6199 | ABM | 1x10^6 cells / 1.0 ml | EUR 3950 |
MDA-MB-231 Cell Line |
|||
CL-0150 | Elabscience Biotech | 1×10⁶ cells/vial | EUR 420 |
Description: Homo sapiens, Human |
MDA-MB-453 Cell Line |
|||
CL-0152 | Elabscience Biotech | 1×10⁶ cells/vial | EUR 420 |
Description: Homo sapiens, Human |
MDA-MB-468 Cell Line |
|||
CL-0290 | Elabscience Biotech | 1×10⁶ cells/vial | EUR 420 |
Description: Homo sapiens, Human |
MDA-MB-415 Cell Line |
|||
CL-0382 | Elabscience Biotech | 1×10⁶ cells/vial | EUR 500 |
Description: Homo sapiens, Human |
MDA-MB-436 Cell Line |
|||
CL-0383 | Elabscience Biotech | 1×10⁶ cells/vial | EUR 500 |
Description: Homo sapiens, Human |
MDA-MB-361 Cell Line |
|||
CL-0553 | Elabscience Biotech | 1×10⁶ cells/vial | EUR 500 |
Description: Homo sapiens, Human |
EDC4 CRISPR Stable Knockout HEK293T Cell Line |
|||
T6241 | ABM | 1x10^6 cells / 1.0 ml | EUR 3950 |
MDA-MB-175VII Cell Line |
|||
CL-0381 | Elabscience Biotech | 1×10⁶ cells/vial | EUR 500 |
Description: Homo sapiens, Human |
DJ-1 CRISPR Stable Knockout HeLa Cell Line |
|||
T6181 | ABM | 1x10^6 cells / 1.0 ml | EUR 3950 |
PDPN CRISPR Stable Knockout COS-7 Cell Line |
|||
T6039 | ABM | 1x10^6 cells / 1.0 ml | EUR 3950 |
PD-L1 CRISPR Stable Knockout CT26 Cell Line |
|||
T6237 | ABM | 1x10^6 cells / 1.0 ml | EUR 3950 |
PD-L1 CRISPR Stable Knockout MC38 Cell Line |
|||
T6149 | ABM | 1x10^6 cells / 1.0 ml | EUR 3950 |
TARGATT? Knock-in iPSC Generation (Master Cell Line) |
|||
AST-1100 | Applied StemCell | 1 vial of 1X10^6 cells | Ask for price |
Description: 6 month |
LIMD1-/- CRISPR Stable Knockout HeLa Cell Line |
|||
T6357 | ABM | 1x10^6 cells / 1.0 ml | EUR 3950 |
Platinum-E Retroviral Packaging Cell Line, Ecotropic |
|||
RV-101 | Cell Biolabs | 1 vial | EUR 770 |
SLC35A1 CRISPR Stable Knockout CHO-S Cell Line |
|||
T6040 | ABM | 1x10^6 cells / 1.0 ml | EUR 3950 |
CXCL1 & CXCL8 CRISPR Double Knockout L3.6pl Cell Line |
|||
T6047 | ABM | 1x10^6 cells / 1.0 ml | Ask for price |
Platinum-GP Retroviral Packaging Cell Line, Pantropic |
|||
RV-103 | Cell Biolabs | 1 vial | EUR 770 |
Platinum-A Retroviral Packaging Cell Line, Amphotropic |
|||
RV-102 | Cell Biolabs | 1 vial | EUR 770 |
Total Protein - Murine Embryonic Stem Cell Line D3 |
|||
CBA-305 | Cell Biolabs | 500 ?g | EUR 414 |
Description:
|
AXL CRISPR Stable Knockout HT1080 (1-IV) Cell Line |
|||
T6232 | ABM | 1x10^6 cells / 1.0 ml | EUR 3950 |
AXL CRISPR Stable Knockout HT1080 (3-II) Cell Line |
|||
T6233 | ABM | 1x10^6 cells / 1.0 ml | EUR 3950 |
PLN Knock-out Human Induced Pluripotent Stem Cells (Episomal, HFF) |
|||
iPS41 | ALSTEM | 1 Vial | EUR 2268 |
LRP1 Knock-out Human Induced Pluripotent Stem Cells (Episomal, HFF) |
|||
iPS31 | ALSTEM | 1 Vial | EUR 2268 |
AFF2 Knock-out Human Induced Pluripotent Stem Cells (Episomal, HFF) |
|||
iPS61 | ALSTEM | 1 Vial | EUR 2268 |
ABCA7 Knock-out Human Induced Pluripotent Stem Cells (Episomal, HFF) |
|||
iPS21 | ALSTEM | 1 Vial | EUR 2268 |
KCNK3 Knock-out Human Induced Pluripotent Stem Cells (Episomal, HFF) |
|||
iPS51 | ALSTEM | 1 Vial | EUR 2268 |
LLGL1 Knock-out Human Induced Pluripotent Stem Cells (Episomal, HFF) |
|||
iPS71 | ALSTEM | 1 Vial | EUR 2268 |
TARGATT? Knock-in CHO Generation Kit (Master Cell Line) |
|||
AST-1200 | Applied StemCell | 1 Kit | Ask for price |
Description: 12 month |
TARGATT? Knock-in HEK293 Generation Kit (Master Cell Line) |
|||
AST-1300 | Applied StemCell | 1 Kit | Ask for price |
Description: 12 month |
EBM 3'UTR GFP Stable Cell Line |
|||
TU056522 | ABM | 1.0 ml | EUR 2799.6 |
Human NFkB Luciferase Reporter Cell Line- MDA-MB-231 |
|||
ABC-RC0026 | AcceGen | 1 vial | Ask for price |
Description: Human NFkB Luciferase Reporter Cell Line- MDA-MB-231 is derived from Human breast cancer, and stably express firefly luciferase reporter gene under the control of NFkB response element. This cell line is an ideal cellular model for monitoring the activation of NFkB response Pathway triggered by stimuli treatment, enforced gene expression and gene knockdown. |
Malondialdehyde (MDA) Modified Human Albumin |
|||
STA-210 | Cell Biolabs | 100 µg | EUR 505.2 |
Description:
|
Human AR Luciferase Reporter Cell Line-MDA-MB-453 |
|||
ABC-RC0005 | AcceGen | 1 vial | Ask for price |
Description: Human AR Luciferase Reporter Cell Line-MDA-MB-453 is derived from human breast cancer,and stably express firefly luciferase reporter gene under the control of the AR response element. This cell line is an ideal cellular model for monitoring the activation of Androgen Receptor Pathway triggered by stimuli treatment, enforced gene expression and gene knockdown. |
Human GR Luciferase Reporter Cell Line-MDA-MB-453 |
|||
ABC-RC0015 | AcceGen | 1 vial | Ask for price |
Description: Human GR Luciferase Reporter Cell Line-MDA-MB-453 is derived from human breast cancer, and stably express firefly luciferase reporter gene under the control of the GR response element. This cell line is an ideal cellular model for monitoring the activation of Glucocorticoid Receptor Signaling Pathway triggered by stimuli treatment, enforced gene expression and gene knockdown. |
Human CRIM1 knockout cell line |
|||
ABC-KH3563 | AcceGen | 1 vial | Ask for price |
Description: Human CRIM1 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human CRIP1 knockout cell line |
|||
ABC-KH3564 | AcceGen | 1 vial | Ask for price |
Description: Human CRIP1 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human CRIP2 knockout cell line |
|||
ABC-KH3565 | AcceGen | 1 vial | Ask for price |
Description: Human CRIP2 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human CRIP3 knockout cell line |
|||
ABC-KH3566 | AcceGen | 1 vial | Ask for price |
Description: Human CRIP3 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human CRIPT knockout cell line |
|||
ABC-KH3568 | AcceGen | 1 vial | Ask for price |
Description: Human CRIPT knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human CRIPAK knockout cell line |
|||
ABC-KH3567 | AcceGen | 1 vial | Ask for price |
Description: Human CRIPAK knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
EBM 3'UTR Luciferase Stable Cell Line |
|||
TU006522 | ABM | 1.0 ml | EUR 2799.6 |
Mouse NACC1 CRISPR Stable Knockout ID8 Cell Line - Clone T1-23 |
|||
T6826 | ABM | 1x10^6 cells / 1.0 ml | EUR 3950 |
Human CRIM1 knockdown cell line |
|||
ABC-KD3563 | AcceGen | 1 vial | Ask for price |
Description: Human CRIM1 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
Human CRIP1 knockdown cell line |
|||
ABC-KD3564 | AcceGen | 1 vial | Ask for price |
Description: Human CRIP1 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
Human CRIP2 knockdown cell line |
|||
ABC-KD3565 | AcceGen | 1 vial | Ask for price |
Description: Human CRIP2 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
Human CRIP3 knockdown cell line |
|||
ABC-KD3566 | AcceGen | 1 vial | Ask for price |
Description: Human CRIP3 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
Human CRIPT knockdown cell line |
|||
ABC-KD3568 | AcceGen | 1 vial | Ask for price |
Description: Human CRIPT knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
Human CRIPAK knockdown cell line |
|||
ABC-KD3567 | AcceGen | 1 vial | Ask for price |
Description: Human CRIPAK knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
GFP Expressing Human MDA-MB-435 |
|||
cAP-0049GFP | Angio Proteomie | 1Frozen Vial | EUR 782.1 |
GFP Expressing Human MDA-MB-435 |
|||
ALHC006-GFP | Alphabioregen | 1ml frozen Vial | EUR 0.2 |
hCETP shRNA (Target C) Knock Down THP-1 Cell Line-Polyclone |
|||
T9789 | ABM | 1x10^6 cells / 1.0 ml | Ask for price |
Human CK-MB ELISA Kit (Creatine Kinase-MB) |
|||
PRB-5047 | Cell Biolabs | 96 assays | EUR 686.4 |
Description: Our Human CK-MB ELISA Kit specifically detects the CK-MB form of Creatine Kinase in serum or plasma samples as well as in lysates. The kit does not detect the CK-MM or CK-BB isotypes. Each kit provides sufficient reagents for 96 wells including standards and unknown samples. |
Human CK-MB ELISA Kit (Creatine Kinase-MB) |
|||
PRB-5047-5 | Cell Biolabs | 5 x 96 assays | EUR 2739.6 |
Description: Our Human CK-MB ELISA Kit specifically detects the CK-MB form of Creatine Kinase in serum or plasma samples as well as in lysates. The kit does not detect the CK-MM or CK-BB isotypes. Each kit provides sufficient reagents for 96 wells including standards and unknown samples. |
Malondialdehyde (MDA) Modified Human Apolipoprotein B-100 |
|||
STA-211 | Cell Biolabs | 100 µg | EUR 748.8 |
Description:
|
Human CEL knockout cell line |
|||
ABC-KH2905 | AcceGen | 1 vial | Ask for price |
Description: Human CEL knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human GC knockout cell line |
|||
ABC-KH5948 | AcceGen | 1 vial | Ask for price |
Description: Human GC knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human GK knockout cell line |
|||
ABC-KH6087 | AcceGen | 1 vial | Ask for price |
Description: Human GK knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human HP knockout cell line |
|||
ABC-KH6972 | AcceGen | 1 vial | Ask for price |
Description: Human HP knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human HR knockout cell line |
|||
ABC-KH6992 | AcceGen | 1 vial | Ask for price |
Description: Human HR knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human KL knockout cell line |
|||
ABC-KH7942 | AcceGen | 1 vial | Ask for price |
Description: Human KL knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human KY knockout cell line |
|||
ABC-KH8250 | AcceGen | 1 vial | Ask for price |
Description: Human KY knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human F2 knockout cell line |
|||
ABC-KH5009 | AcceGen | 1 vial | Ask for price |
Description: Human F2 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human F3 knockout cell line |
|||
ABC-KH5014 | AcceGen | 1 vial | Ask for price |
Description: Human F3 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human F5 knockout cell line |
|||
ABC-KH5015 | AcceGen | 1 vial | Ask for price |
Description: Human F5 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human F7 knockout cell line |
|||
ABC-KH5016 | AcceGen | 1 vial | Ask for price |
Description: Human F7 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
In this examine, nanoindentation and nanowear properties of SLM manufactured CP-Ti and EBM manufactured Ti64 gyroid scaffolds with completely different unit cell sizes and pattern orientations have been evaluated and in contrast to solid dense CP-Ti samples. Moreover, the in vitro biocompatibility of the scaffolds was assessed and in contrast to one another. To our greatest of information, this type of examine on EBM/SLM manufactured CP-Ti and Ti64 scaffolds haven’t been reported, to date.